According to our report, the size of the global hemostats market was worth USD 3.38 billion in 2020 and is expected to grow at a CAGR of 6.2% to reach USD 4.57 billion by 2025.
In order to stop bleeding during an operation on a patient, hemostats are used. Tissue adhesion agents and tissue sealants are used alongside it. These adhesives and sealants can be physical or biological. These products are predicted to replace soon the traditional sutures used for incision closures. It is because they are minimally invasive and reduce the time of surgery, along with preventing any post-operation fluid leaks or infections.
Several factors are driving the growth of this market. Some of them are rapid advancements in technology, numerous applications, well-funded R&D, robust insurance support to manufacturers, etc.
However, there are some factors which are inhibiting the market growth. They are strict regulatory procedures and administrative frameworks and low awareness about these products amongst the consumers.
REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2019 to 2025 |
Base Year |
2019 |
Forecast Period |
2020 to 2025 |
Segments Covered |
By Product Type, Application, Distribution Channel, End-User and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This market research report on the global hemostats market has been segmented and sub-segmented based on the product type, application, distribution channel, end-user, and region.
Hemostats Market – By Product Type:
In 2018, thrombin based hemostats market sub-category accounted for the largest market share. Its growth rate will remain steady in the forecast period. Gelatine based topical hemostats are growing in demand because they are economical. However, they are available in powder form.
Hemostats Market – By Application:
Hemostats Market – By Distribution Channel:
Hemostats Market – By End User:
Hemostats Market – By Region:
Geographically, North America accounted for the largest share in the global hemostats market in 2019 and is expected to remain at the top until the end of 2025. Highly advanced healthcare systems in this region, coupled with their ready adoption, are the factors attributable to the observable trend mentioned above. The Asia Pacific is set on a high growth trajectory in the aforementioned forecast period. The booming medical tourism industry, rising disposable income resulting in higher purchasing power, and rising awareness regarding better health infrastructure are the reasons behind this.
TOP COMPANIES IN THE MARKET
Key players in the global hemostats market include 3M, ADCO Global, Inc., Abbott Laboratories. Other players in the market include Advanced Medical Solutions Group, Plc. and Dymax Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Topical hemostats
5.1.2.1 Collagen-based topical hemostats
5.1.2.2 Oxidized regenerated cellulose-based topical hemostat
5.1.2.3 Gelatin-based topical hemostat
5.1.2.4 Thrombin-based topical hemostat
5.1.2.5 Combination topical hemostat
5.1.3 Tissue Sealants
5.1.3.1 Fibrin sealants
5.1.3.2 Protein-based sealants
5.1.4 Cyanoacrylate-based tissue adhesives
5.1.5 Adhesion prevention products
5.1.6 Y-o-Y Growth Analysis, By Product Type
5.1.7 Market Attractiveness Analysis, By Product Type
5.1.8 Market Share Analysis, By Product Type
5.2 Application
5.2.1 Wound Closure
5.2.2 Surgical Hemostats
5.2.3 Y-o-Y Growth Analysis, By Application
5.2.4 Market Attractiveness Analysis, By Application
5.2.5 Market Share Analysis, By Application
5.3 Distribution Channel
5.3.1 Direct Tenders
5.3.2 Retail
5.3.3 Y-o-Y Growth Analysis, By Distribution Channel
5.3.4 Market Attractiveness Analysis, By Distribution Channel
5.3.5 Market Share Analysis, By Distribution Channel
5.4 End User
5.4.1 Hospitals
5.4.2 Ambulatory Centers
5.4.3 Community Healthcare
5.4.4 Clinics
5.4.5 Y-o-Y Growth Analysis, By End User
5.4.6 Market Attractiveness Analysis, By End User
5.4.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product Type
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Johnson & Johnson Services, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 C. R. Bard, Inc.
8.3 Baxter
8.4 B. Braun Melsungen Ag
8.5 Pfizer Inc.
8.6 Vascular Solutions, Inc.
8.7 Gelita Medical Gmbh
8.8 Equimedical
8.9 Integra Lifesciences Holdings Corporation
8.10 Z-Medica, LLC
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Feb 2020
Feb 2020